ADMA Biologics, Inc.ADMANASDAQ
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
-19.7%/yr
vs +36.7%/yr prior
5Y CAGR
-3.9%/yr
Recent deceleration
Acceleration
-56.4pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $79.89M | -2.7% |
| 2024 | $82.12M | -41.9% |
| 2023 | $141.42M | -8.4% |
| 2022 | $154.44M | +50.1% |
| 2021 | $102.92M | +5.4% |
| 2020 | $97.67M | +15.3% |
| 2019 | $84.73M | +91.6% |
| 2018 | $44.22M | +2.9% |
| 2017 | $42.97M | +112.1% |
| 2016 | $20.26M | - |